Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by TexRitteron Dec 18, 2017 9:22pm
176 Views
Post# 27183611

RE:RE:RE:Leadership

RE:RE:RE:LeadershipI think it is safe to say that Booth is less tempered than Battley - he is not one to sit back and take it -  which I have no problem with. No doubt both took Zettl's comments about Aurora personally (ie calling it paper money, overvalued, and backfilling with quality companies for 3 of many very offside comments). Booth made one comment in the Aurora release that some tenderfeet may be upset over - the, "it doesn't take a genius" bit, which I think shows a bit of emotion which, again, I am fine with but is not necessary - it is obvious that this is the case - you don't have to be a genius to see that the Newstrike deal is a bad deal. So if I understand your question, I think there are a couple of people that are horrified at this comment, as there was absolutely nothing else in the statement that anyone could take umbrage with. I was addressing their posts which tend to be very critical of Booth - I think unfairly - while painting Zettl as this charming town dandy, where he was the one flinging poo like a baboon on methamphetamine.

Hope that answers your q. Again, I think the statement was absolutely required for reasons I set out in other posts, and I think aside from that one comment was very objective and provided Cmed shareholders with legitimate facts they can check for themselves, something they would not be getting from their own company in this case. 
Bullboard Posts